Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel prognostic model based on six methylation-driven genes predicts overall survival for patients with clear cell renal cell carcinoma. | Front Genet | 2022 | 36330441 | PubTator, text mining | PubMed |
| A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer. | Front Immunol | 2022 | 36325340 | PubTator, text mining | PubMed |
| Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylation. | iScience | 2022 | 36325065 | PubTator, text mining | PubMed |
| Parallel functional annotation of cancer-associated missense mutations in histone methyltransferases. | Sci Rep | 2022 | 36323913 | PubTator, text mining | PubMed |
| FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. | Nat Commun | 2022 | 36323682 | PubTator, text mining | PubMed |
| Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity. | Nat Commun | 2022 | 36323669 | PubTator, text mining | PubMed |
| FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis. | Nat Commun | 2022 | 36319643 | PubTator, text mining | PubMed |
| Copy number variant analysis for syndromic congenital heart disease in the Chinese population. | Hum Genomics | 2022 | 36316717 | PubTator, text mining | PubMed |
| m6A/ m1A /m5C/m7G-related methylation modification patterns and immune characterization in prostate cancer. | Front Pharmacol | 2022 | 36313300 | PubTator, text mining | PubMed |
| Mutations in lysine methyltransferase 2C and PEG3 are associated with tumor mutation burden, prognosis, and antitumor immunity in pancreatic adenocarcinoma patients. | Digit Health | 2022 | 36312851 | PubTator, text mining | PubMed |
| Application of exome sequencing for prenatal diagnosis of fetal structural anomalies: clinical experience and lessons learned from a cohort of 1618 fetuses. | Genome Med | 2022 | 36307859 | PubTator, text mining | PubMed |
| Identification and validation of a genomic mutation signature as a predictor for immunotherapy in NSCLC. | Biosci Rep | 2022 | 36305643 | PubTator, text mining | PubMed |
| Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations. | Cancers (Basel) | 2022 | 36291897 | PubTator, text mining | PubMed |
| Clinical Practice of Targeted Capture Sequencing to Identify Actionable Alterations in Cholangiocarcinoma. | Cancers (Basel) | 2022 | 36291846 | PubTator, text mining | PubMed |
| Genomic Instability in Cerebrospinal Fluid Cell-Free DNA Predicts Poor Prognosis in Solid Tumor Patients with Meningeal Metastasis. | Cancers (Basel) | 2022 | 36291812 | PubTator, text mining | PubMed |
| Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas. | Cancers (Basel) | 2022 | 36291756 | PubTator, text mining | PubMed |
| Role of Extracellular Vesicles in Thyroid Physiology and Diseases: Implications for Diagnosis and Treatment. | Biomedicines | 2022 | 36289847 | PubTator, text mining | PubMed |
| Subtype-specific 3D genome alteration in acute myeloid leukaemia. | Nature | 2022 | 36289338 | PubTator, text mining | PubMed |
| Phenotypic plasticity and genetic control in colorectal cancer evolution. | Nature | 2022 | 36289336 | PubTator, text mining | PubMed |
| Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors. | Bladder Cancer | 2022 | 36277328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=50